Hungta Chen

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Lower mortality with andexanet alfa vs 4-factor prothrombin complex concentrate for factor Xa inhibitor-related major bleeding in a U.S. hospital-based observational study”.

Lower mortality with andexanet alfa vs 4-factor prothrombin complex concentrate for factor Xa inhibitor-related major bleeding in a U.S. hospital-based observational study

Research and Practice in Thrombosis and Haemostasis(2023)10.1016/j.rpth.2023.102192

N/A

1.4DataRank · unranked

31 citations

Gregory J. Fermann, Mary J. Christoph, Bruce Koch, Eva Lesén, Hungta Chen +7 more

Global use of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes. Results from DISCOVER

BMC Endocrine Disorders(2022)10.1186/s12902-022-01026-2

N/A

0DataRank · unranked

81 citations

Fengming Tang, Andrew Cooper, Hungta Chen, Marília Brito Gomes, Wolfgang Rathmann +6 more

Association of country economy and socioeconomic factors on risk factor control for primary prevention of cardiovascular disease in patients with diabetes mellitus: Insights from the DISCOVER study

Indian Heart Journal(2022)10.1016/j.ihj.2022.07.008

N/A

0DataRank · unranked

2 citations

Hungta Chen, Fengming Tang, Paul Chan, Andrew Cooper, Marília Brito Gomes +11 more

Reply to “Letter to Dobesh et al. on lower mortality with andexanet alfa in factor Xa inhibitor–related major bleeding”

Research and Practice in Thrombosis and Haemostasis(2024)10.1016/j.rpth.2024.102429

N/A

0DataRank · unranked

0 citations

Gregory J. Fermann, Mary J. Christoph, Bruce Koch, Eva Lesén, Hungta Chen +7 more